Targeted microwave ablation for prostate cancer (FOSTINE1b): a prospective 'ablate-and-resect' study.
Alexandre PeltierRoland van VelthovenArthur BaudewynsGrégoire AssenmacherMarc LemortYolene LefebvreNicolas SirtaineRomain DiamandPublished in: BJU international (2024)
Targeted microwave ablation via the Trinity system for localised PCa treatment proves to be a secure and feasible procedure, with complete necrosis evidence within the ablation zone on surgical specimens.